News

Six coronavirus research projects, including two focused on vaccine development, will be the first to benefit from a share of £20 million in UK government investment.

The U.S. Food and Drug Administration (FDA) has issued guidance for industry, investigators and institutional review boards conducting clinical trials during the novel coronavirus (COVID-19) pandemic.

The substance named Lu AF60097 may help reduce side effects from tricyclic antidepressants in those with severe depression.

Two cryo-electron microscopy (cryo-EM) structures have been determined of the human glucagon receptor in complex with its cognate agonist glucagon and distinct classes of G proteins, Gs or Gi.

Vivli, the Center for Clinical Research Data, is launching a COVID-19 portal for sharing of completed interventional treatment trial data.

To further reduce the risk of transmission of COVID-19 and for the safety of staff, the National Institutes of Health (NIH) is shifting all non-mission-critical laboratory operations to a maintenance phase.

A system that can concurrently transmit light and energy to underwater energy devices is under development at KAUST. Self-powered internet of underwater things (IoUT) that harvest energy and decode information transferred by light beams can enhance sensing and communication in the seas and oceans.

University of Massachusetts Amherst researchers have invented a portable surveillance device powered by machine learning - called FluSense - which can detect coughing and crowd size in real time, then analyze the data to directly monitor flu-like illnesses and influenza trends.

Chemists at Texas A&M University are taking a p[h]age from bacteria’s playbook in order to beat viruses at their own game and develop new drugs to fight cancer and a host of other human diseases in the process.

Up to $2.86 M has been awarded to a research team including Penn State researchers to develop a novel oral antibiotic to treat multidrug-resistant gonorrhea.